CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment
Femke H. Bouwman(Amsterdam UMC Location Vrije Universiteit Amsterdam), Philip Scheltens(Inserm), Astrid Kok(Amsterdam UMC Location VUmc), Marinus A. Blankenstein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frederik Barkhof(Netherlands Institute for Neuroscience), S.N.M. Schoonenboom(Amsterdam UMC Location VUmc), Evert J. van Elk(Amsterdam UMC Location VUmc), Wiesje M. van der Flier(Amsterdam Neuroscience)
Cited by 180
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k